ATXS

Astria Therapeutics
ATXS

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$293.46M
EV
$66.00M
Shares Outstanding
58.01M
Beta
0.68

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$26.50
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Astria Therapeutics, Inc.

gainify
ATXS

Astria Therapeutics, Inc.

ATXS

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor ...

Sector

Healthcare

Industry

Biotechnology

CEO

Milne, Jill

Employees

78

IPO Date

2015-06-25

Headquarters

75 State Street, Suite 1400, Boston, Massachusetts, 02109, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved